Production (Stage)
Biohaven Ltd.
BHVN
$15.06
-$0.28-1.83%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 95.95M | 89.24M | 85.68M | 80.15M | 75.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 912.53M | 874.21M | 848.89M | 781.27M | 541.51M |
| Operating Income | -912.53M | -874.21M | -848.89M | -781.27M | -541.51M |
| Income Before Tax | -887.82M | -845.69M | -804.86M | -750.36M | -518.93M |
| Income Tax Expenses | 775.00K | 735.00K | -525.00K | -3.75M | -1.75M |
| Earnings from Continuing Operations | -888.60 | -846.42 | -804.34 | -746.61 | -517.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -888.60M | -846.42M | -804.34M | -746.61M | -517.18M |
| EBIT | -912.53M | -874.21M | -848.89M | -781.27M | -541.51M |
| EBITDA | -903.88M | -866.36M | -841.60M | -774.44M | -534.80M |
| EPS Basic | -9.37 | -9.39 | -9.35 | -9.16 | -6.84 |
| Normalized Basic EPS | -5.92 | -5.94 | -6.00 | -5.90 | -4.44 |
| EPS Diluted | -9.37 | -9.39 | -9.35 | -9.16 | -6.84 |
| Normalized Diluted EPS | -5.92 | -5.94 | -6.00 | -5.90 | -4.44 |
| Average Basic Shares Outstanding | 385.14M | 364.80M | 343.67M | 317.62M | 298.10M |
| Average Diluted Shares Outstanding | 385.14M | 364.80M | 343.67M | 317.62M | 298.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |